ASF 1081

Drug Profile

ASF 1081

Alternative Names: ASF-1081

Latest Information Update: 27 Mar 2006

Price : $50

At a glance

  • Originator Astion Pharma A/S
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Clinical Phase Unknown Atopic dermatitis

Most Recent Events

  • 27 Mar 2006 Clinical trials in Atopic dermatitis in Denmark (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top